Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Titel:
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Auteur:
Berthon, Céline Raffoux, Emmanuel Thomas, Xavier Vey, Norbert Gomez-Roca, Carlos Yee, Karen Taussig, David Christopher Rezai, Keyvan Roumier, Christophe Herait, Patrice Kahatt, Carmen Quesnel, Bruno Michallet, Mauricette Recher, Christian Lokiec, François Preudhomme, Claude Dombret, Hervé